Current and Future Treatment of Retinitis Pigmentosa

Cross N, van Steen C, Zegaoui Y, Satherley A, Angelillo L.

2022
Clin Ophthalmol

View publication

Therapeutic Area

Back of the eye (BOTE)
Technology

Gene / Cell Therapy
Categories

Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

Affiliations

Market Access, Lightning Health, London, UK.; Market Access, Health Technology Assessment & Health Economics and Outcome Research, Europe, the Middle East and Africa, Santen GmbH, Munich, Bavaria, Germany

Related Publications

Aging-associated changes of optical coherence tomography-measured ganglion cell-related retinal layer thickness and visual sensitivity in normal Japanese

Iwase A., Higashide T., Fujii M., Ohno Y., Tanaka Y., Kikawa T., Araie M.

Atropine Ophthalmic Solution to Reduce Myopia Progression in Pediatric Subjects: The Randomized, Double-Blind Multicenter Phase II APPLE Study

Chia A, Ngo C, Choudry N, Yamakawa Y, Tan D

Efficacy of lutein supplements on macular pigment optical density in highly myopic individuals: A randomized controlled trial

Yoshida T.; Takagi Y.; Igarashi-Yokoi T.; Ohno-Matsui K.

View all Back of the eye (BOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022